Evolution of the Average Target: Cardiol Therapeutics Inc.

Evolution of the Target Price: Cardiol Therapeutics Inc.

Changes in Analyst Recommendations: Cardiol Therapeutics Inc.

ad3.QoMoGBd398vnTiKeSdM-r2aoI7oiOOSOGqkVSwyOyHg.O-FZUiRa2rjVIGTSB4NRyVL5afZ3epfdSc9EHG3GsU8y5VleVgaFiq47Fg~25d8090be04355bec77362b59faada9f

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+310.96%
+35.33%
+21.72%
+25.07%
+55.91%
+46.2%
-5.24%
+10.62%
+39.43%
Average +60.00%
Weighted average by Cap. +32.02%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.460CAD
Average target price
6.000CAD
Spread / Average Target
+310.96%
High Price Target
7.000CAD
Spread / Highest target
+379.45%
Low Price Target
5.000CAD
Spread / Lowest Target
+242.47%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Canaccord Genuity
HC Wainwright
Cantor Fitzgerald
Raymond James
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.460CAD
Average target price
6.000CAD
Spread / Average Target
+310.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CRDL Stock
  4. Consensus Cardiol Therapeutics Inc.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!